Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. [electronic resource]
Producer: 20031211Description: 2693-702 p. digitalISSN:- 1538-3598
- Adult
- Akathisia, Drug-Induced
- Antipsychotic Agents -- adverse effects
- Benzodiazepines
- Benztropine -- therapeutic use
- Double-Blind Method
- Female
- Haloperidol -- adverse effects
- Health Care Costs
- Health Services -- statistics & numerical data
- Humans
- Male
- Middle Aged
- Muscarinic Antagonists -- therapeutic use
- Neuropsychological Tests
- Olanzapine
- Pirenzepine -- adverse effects
- Quality of Life
- Schizophrenia -- drug therapy
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.